- Additional new data demonstrate VY-TAU01, Voyager’s lead antibody targeting pathological tau, was well-tolerated and demonstrated favorable pharmacokinetics in non-human…
SAN FRANCISCO, Feb. 20, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2023…
10-year collaboration aims to expand the reach of innovative technology and digital solutions to more than one million patients. CHICAGO--(BUSINESS…
Significant efforts lie ahead, as the Black Book survey reveals that only 37% of medical practice respondents are receiving value-based…
CHICAGO, IL / ACCESSWIRE / February 19, 2024 / The American Society for Transplantation and Cellular Therapy® (ASTCT®) supports the…
The operating margins of US rural and critical access hospitals have radically decreased, leaving these challenged institutions in a financially…
As doctors balance the risks and benefits of pain management, PillSafe technology ensures the managed delivery and distribution of controlled…
LONDON, UK / ACCESSWIRE / February 19, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF)('Poolbeg' or the 'Company'), a biopharmaceutical company focussed on…
Senior Life Solutions supports the mental health of older adults with psychiatry and group therapy.SHATTUCK, OK / ACCESSWIRE / February…
REDWOOD CITY, CA / ACCESSWIRE / February 19, 2024 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS)…